Gilles Manceau

Analysis of <i>PTEN</i> , <i>BRAF</i> , and <i>EGFR</i> Status in Determining Benefit From Cetuximab Therapy in Wild-Type <i>KRAS</i> Metastatic Colon Cancer

Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau et al. · Journal of Clinical Oncology · 2009 · 665 citations

Medicine, Oncology, Pharmacology +17

A Step Toward NOTES Total Mesorectal Excision for Rectal Cancer

Jean–Jacques Tuech, Mehdi Karoui, Bernard Lelong et al. · Annals of Surgery · 2014 · 198 citations

Medicine, Oncology, Surgery +17

Bowel dysfunction after anastomotic leakage in laparoscopic sphincter-saving operative intervention for rectal cancer: A case-matched study in 46 patients using the Low Anterior Resection Score

Élisabeth Hain, Gilles Manceau, Léon Maggiori et al. · Surgery · 2016 · 106 citations

Medicine, Oncology, Surgery +17

Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

Gilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut et al. · Clinical Cancer Research · 2014 · 102 citations

Medicine, Oncology, Pathology +17

Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict <i>KRAS</i> mutations before surgery

Jérôme Alexandre Denis, A. Patroni, Erell Guillerm et al. · Molecular Oncology · 2016 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17